UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000006970
Receipt number R000008230
Scientific Title A placebo controlled phase III double blind study of ITK-1 -The efficacy and safety evaluation of ITK-1 in Temozolomide refractory Glioblastoma patients with HLA-A24 positive-
Date of disclosure of the study information 2012/01/04
Last modified on 2019/10/30 15:14:44

No. Disposal Last modified on Item of update
1 Insert 2011/12/28 10:27:35
2 Update 2012/01/04 09:47:06 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Date of disclosure of the study information
3 Update 2012/08/01 18:30:29 Homepage URL
IND to MHLW
Institutions
4 Update 2012/08/02 16:35:16 Email1
5 Update 2014/08/06 18:53:45 TEL
Email
Name of person sending information
Name of person sending information
Division name
Division name
Address
Address
TEL
Email
6 Update 2015/01/28 14:51:51 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
7 Update 2015/01/28 14:58:52 Email
Institute
Institute
Email1
Institutions
8 Update 2016/01/28 10:33:46 Interventions/Control_1
Interventions/Control_2
9 Update 2016/01/28 10:36:57 Organization
Organization
10 Update 2016/06/06 13:50:50 Recruitment status
11 Update 2017/01/04 10:31:43 Email
Homepage URL
Name of primary person or sponsor
Organization
Category of Funding Organization
12 Update 2019/10/30 15:14:44 Recruitment status
Date of IRB